ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics
American Journal of Nuclear Medicine and Molecular Imaging · 2026 · 16 (3) · 157-161
DOI: 10.62347/lknt6446 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Steven H Liang. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Emory University 1364 Clifton Road, Atlanta, Georgia 30322, The United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Imaging Sciences, Emory University 1364 Clifton Road, Atlanta, Georgia 30322, The United States.
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University Atlanta, Georgia 30332, The United States.
Zitieren
APA
Liang, S. H. (2026). ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics. American Journal of Nuclear Medicine and Molecular Imaging, 16(3), 157-161. https://doi.org/10.62347/lknt6446
Vancouver
Liang SH. ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics. American Journal of Nuclear Medicine and Molecular Imaging. 2026;16(3):157-161. doi:10.62347/lknt6446
BibTeX
@article{Liang2026,
author = {Liang, Steven H},
title = {ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {16},
number = {3},
pages = {157--161},
doi = {10.62347/lknt6446}
}
EUVIMED